Gene · 51330
Papers2,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The TGF-β Family in Glioblastoma. | Int J Mol Sci | 2024 | 38256140 | PubTator, text mining | PubMed |
| Adipose Stromal Cell-Derived Secretome Attenuates Cisplatin-Induced Injury In Vitro Surpassing the Intricate Interplay between Proximal Tubular Epithelial Cells and Macrophages. | Cells | 2024 | 38247813 | PubTator, text mining | PubMed |
| CircNUP50 is a novel therapeutic target that promotes cisplatin resistance in ovarian cancer by modulating p53 ubiquitination. | J Nanobiotechnology | 2024 | 38243224 | PubTator, text mining | PubMed |
| Identification of an inflammation-related risk signature for prognosis and immunotherapeutic response prediction in bladder cancer. | Sci Rep | 2024 | 38216619 | PubTator, text mining | PubMed |
| Exercise microdosing for skeletal muscle health applications to spaceflight. | J Appl Physiol (1985) | 2024 | 38205550 | PubTator, text mining | PubMed |
| CD163 protein inhibits lipopolysaccharide-induced macrophage transformation from M2 to M1 involved in disruption of the TWEAK-Fn14 interaction. | Heliyon | 2024 | 38148798 | PubTator, text mining | PubMed |
| Unbiased Single-Cell Sequencing of Hematopoietic and Immune Cells from Aplastic Anemia Reveals the Contributors of Hematopoiesis Failure and Dysfunctional Immune Regulation. | Adv Sci (Weinh) | 2024 | 38145351 | PubTator, text mining | PubMed |
| Anoikis-related gene CDKN2A predicts prognosis and immune response and mediates proliferation and migration in thyroid carcinoma. | Transl Oncol | 2024 | 38141377 | PubTator, text mining | PubMed |
| Transdermal delivery of Fn14 siRNA using a novel composite ionic liquid for treatment of psoriasis-like skin lesions. | J Control Release | 2024 | 38070601 | PubTator, text mining | PubMed |
| The expression of immune related genes and potential regulatory mechanisms in schizophrenia. | Schizophr Res | 2024 | 37993327 | PubTator, text mining | PubMed |
| Midnight Cortisol is Associated with Changes in Systolic Blood Pressure and Diabetic Neuropathy in Subjects with Type 1 Diabetes Undergoing Simultaneous Kidney-Pancreas Transplantation. | Diabetes Ther | 2024 | 37917327 | PubTator, text mining | PubMed |
| Integrating bulk and single-cell data to predict the prognosis and identify the immune landscape in HNSCC. | J Cell Mol Med | 2024 | 37882107 | PubTator, text mining | PubMed |
| Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy. | Front Mol Biosci | 2023 | 38274096 | PubTator, text mining | PubMed |
| Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model. | Front Immunol | 2023 | 38259435 | PubTator, text mining | PubMed |
| Endometrial immune profiling as a new tool for preconceptional assessment in patients with systemic autoimmune diseases. | Front Immunol | 2023 | 38250081 | PubTator, text mining | PubMed |
| Leveraging technology-driven strategies to untangle omics big data: circumventing roadblocks in clinical facets of oral cancer. | Front Oncol | 2023 | 38234400 | PubTator, text mining | PubMed |
| A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. | Biomedicines | 2023 | 38137450 | PubTator, text mining | PubMed |
| Morphological changes of macular neovascularization during long-term anti-VEGF-therapy in neovascular age-related macular degeneration. | PLoS One | 2023 | 38134207 | PubTator, text mining | PubMed |
| Exploring the advances of single-cell RNA sequencing in thyroid cancer: a narrative review. | Med Oncol | 2023 | 38129369 | PubTator, text mining | PubMed |
| COVID-19 and influenza infections mediate distinct pulmonary cellular and transcriptomic changes. | Commun Biol | 2023 | 38092883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51330/papers?page=9